Acute thrombocytopenia induced by trastuzumab due to complement reaction: A case report

BACKGROUND: The usual treatment option for HER2 breast cancer is targeted therapy with trastuzumab. The common adverse effects of trastuzumab treatment are thrombocytopenia, however, acute thrombocytopenia is rare and its mechanism is still largely unknown. CASE PRESENTATION: We reported a patient w...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Guoping, Ou, Jianghua, Liu, Jun, Liao, Haoran, Ding, Linwei, Fan, Pingming, Du, Guankui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763998/
https://www.ncbi.nlm.nih.gov/pubmed/36561721
http://dx.doi.org/10.3389/fmed.2022.1037493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763998/
https://www.ncbi.nlm.nih.gov/pubmed/36561721
http://dx.doi.org/10.3389/fmed.2022.1037493

Ejemplares similares